I hate it when I fit the mold for some not-so-great research finding. Like the recent news about how women with early-stage cancer of the left breast (that's me) who are treated with radiation following lumpectomy (me again) face an increased risk of developing radiation-related coronary damage.

OK, so the benefits of radiation therapy still outweigh the risks. Still, when radiation is applied to the breast on the same side as the heart, there are worries. I knew about these concerns. My radiation oncologist addressed them prior to my treatment. Hearing that an actual, important, convincing study confirms what I already knew may be a side effect, though, makes my heart race a little bit more.

There were 961 women with stage I and II breast cancer who were followed in this study. Well, the arteries in their hearts were studied anyway. Some had left-sided breast cancer; the others had right-sided. Some 12 years after radiation, 46 of the 485 left-sided women and 36 of the right-sided group needed cardiac stress testing. Among those tested, 59 percent in the left-sided group had abnormalities. Only 8 percent in the right-sided group showed problems.

Heavy head. Heavy body. Sore throat. Sore gums. Swollen lymph nodes. Fever blister. Hurts to chew. Hurts to swallow. Hurts to recall last time symptoms appeared. During chemotherapy.

Drugs attacking cells. Body weak. Blood counts plummeting. Body crashing. Headache. Fever. Sore throat. Sore gums. Trip to hospital. For five days. For antibiotics. For opinions. For constant monitoring. For daily shots to rebuild blood.

Phone call to dentist who knows my burden. Of worry. And fear. And anxiety. That never really goes away. Always reappears. A virus, he says. All of it. The throat. The gums. The lymph nodes. The fever blister. Nothing more. Should last five to seven days. Don't worry. Relax. Call if it gets worse.

Feeling better. Feeling emotional. Because people are so kind. Like my dentist. Who eased my mind. Soothed my soul.

Time to march forward. For myself. For today.

He an unlikely breast cancer survivor -- because he is a man. But still he developed the disease that roughly 1,700 men will contract this year. And while that statistics pertaining to women and men with breast cancer differ -- women are 100 times more likely to get the disease -- the biology of the disease is exactly the same. Under the microscope, breast cancer is breast cancer. It does not behave any differently in female and male bodies. And detection, treatment, and survival rates are nearly identical for both sexes.

Bob Riter, 49, was diagnosed with breast cancer in 1996. Now in remission, he works as the associate director of the Ithaca Breast Cancer Alliance in New York where he speaks out and educates the public about this widespread disease. He believes his personal story, with its different twist, prompts people to really listen.

Riter's audiences learn that breast cancer in men usually presents itself as a lump in the chest, dimpling of the skin, or changes in the nipple. Doctors can perform breast exams, mammography, and biopsy to investigate the possibility of the cancer that typically strikes men between the ages of 60 and 70. Treatment includes mastectomy to remove the tumor and surrounding lymph nodes, chemotherapy, radiation, and hormone therapy.

It was the presence of blood coming from his nipple that sent Riter to his doctor -- and then to a surgeon who declared a diagnosis of breast cancer. Riter is somewhat of an exception because he reported to his doctor immediately. Most men do not. Many do not even realize they are at risk of breast cancer so they ignore symptoms. They also may go underground with their suspicions of breast cancer because of embarrassment. Both can lead to diagnoses of more advanced diseases.

Riter is doing his part to enlighten both men and women that men are not immune to breast cancer, that they should be active in monitoring their breast health. "I really like to go to national breast cancer meetings," he says, "because a lot of people know that men get breast cancer in theory, but until you have a face to associate with it, it's fairly abstract. And so I'm sort of that face."

On August 9, Patty was diagnosed with breast cancer. She is 36 years old, a wife, a mother of four children -- and already a fighter in her battle that has just begun. So far, she has endured surgery, and she will soon proceed through months of intensive chemotherapy, one year of Herceptin treatment, and weeks and weeks of radiation. It's a familiar path for so many women -- a path marked by devastation, fear, worry, and panic. Yet if there is a gift that flows from cancer, it must be the support and concern and love that can cushion the blow delivered by this disease.

Patty has an abundance of support -- and it all starts with her husband, ironically an administrator of two cancer centers, who is blogging her journey with great strength and an overwhelming love for his wife whose own mother died of breast cancer in 1992 at the age of 46. Patty and her husband have been vigilant about monitoring her health over the years -- in light of her family history -- and Patty had been tested, screened, biopsied, and examined many times before her diagnosis. When her recent tests and biopsies revealed breast cancer, it was both shocking and expected.

Now Patty and her husband -- who authors the blog Patty's Journey -- are expecting the best of outcomes on this journey of a lifetime.

Herceptin -- a targeted breast cancer drug used to treat women who are Her2 positive -- has received rave reviews and has shown great promise in cutting down on recurrence of this aggressive form of breast cancer. Given over the course of 52 weeks, Herceptin is wondrous for its lack of short-term side effects. There is no hair loss, no compromise of blood counts, no significant sickness. For me, fatigue may have resulted from this treatment -- but it's unclear to me really whether it was the Herceptin or the two small boys I have living in my house that most contributed to my occasional exhaustion. Regardless, I functioned well while receiving Herceptin for the past year -- and I did not suffer anything more than a twinge of pain when my port was accessed for each treatment. In the short term, I have fared well. In the long term, the jury is still out.